Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood

Human Immunology

Volumn 71, Issue 3, 2010, Pages 225-234

  Mazza, Graziella ^a   Sabatos Peyton, Catherine A ^a   Protheroe, Rachel E ^a   Herman, Andrew ^a   Campbell, John D ^b   Wraith, David C ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MILTENYI BIOTEC GMBH   (Germany)

Author keywords

Induced regulatory T cells; Interleukin 10

Indexed keywords

CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN SPECIFICITY; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG RESEARCH; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS; ANTIGENS, CD; BLOOD CIRCULATION; BYSTANDER EFFECT; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION;

EID: 76949106053     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.12.003     Document Type: Article

References (50)

1. + T cells and the control of autoimmune disease. Curr Opin Immunol 16 (2004) 695-701
2. Weiner H.L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol Rev 182 (2001) 207-214
3. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
4. Battaglia M., Gregori S., Bacchetta R., and Roncarolo M.G. Tr1 cells: From discovery to their clinical application. Semin Immunol 18 (2006) 120-127
5. Burkhart C., Liu G.Y., Anderton S.M., Metzler B., and Wraith D.C. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: A role for IL-10. Int Immunol 11 (1999) 1625-1634
6. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 (1997) 737-742
7. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
8. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., and Roncarolo M.G. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166 (2001) 5530-5539
9. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195 (2002) 603-616
10. Roncarolo M.G., Gergori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212 (2006) 28-50
11. Xystrakis E., Kusumakar S., Boswell S., Peek E., Urry Z., Richards D.F., et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116 (2006) 146-155
12. + cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 (2003) 388-392
13. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192 (2000) 1213-1222
14. Buer J., Lanoue A., Franzke A., Garcia C., von Boehmer H., and Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med 187 (1998) 177-183
15. Meiler F., Zumkehr J., Klunker S., Ruckert B., Akdis C.A., and Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205 (2008) 2887-2898
16. Sundstedt A., O'Neill E.J., Nicolson K.S., and Wraith D.C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 170 (2003) 1240-1248
17. Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 8 (2002) 1024-1032
18. - Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204 (2007) 285-297
19. - Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204 (2007) 273-283
20. Miller C., Ragheb J.A., and Schwartz R.H. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med 190 (1999) 53-64
21. Sundstedt A., Hoiden I., Rosendahl A., Kalland T., van Rooijen N., and Dohlsten M. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo. J Immunol 158 (1997) 180-186
22. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M., and Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167 (2001) 1945-1953
23. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 (2001) 3789-3796
24. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
25. Reefer A.J., Carneiro R.M., Custis N.J., Platts-Mills T.A., Sung S.S., Hammer J., et al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 172 (2004) 2763-2772
26. Cong Y., Weaver C.T., Lazenby A., and Elson C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J Immunol 169 (2002) 6112-6119
27. Qin S., Cobbold S.P., Pope H., Elliott J., Kioussis D., Davies J., et al. "Infectious" transplantation tolerance. Science 259 (1993) 974-977
28. Bacchetta R., Bigler M., Touraine J.L., Parkman R., Tovo P.A., Abrams J., et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 179 (1994) 493-502
29. Bettelli E., Nicholson L.B., and Kuchroo V.K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J Autoimmun 20 (2003) 265-267
30. Samoilova E.B., Horton J.L., and Chen Y. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: Roles of interleukin-10 in disease progression and recovery. Cell Immunol 188 (1998) 118-124
31. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., and Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med 189 (1999) 1005-1010
32. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 204 (2007) 239-243
33. Gabryšová L., Nicolson K.S., Streeter H.B., Verhagen J., Sabatos-Peyton C.A., Morgan D.J., et al. Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 206 (2009) 1755-1767
34. + T cell clones and peripheral blood T cells. J Immunol 149 (1992) 2378-2384
35. Haringer B., Lozza L., Steckel B., and Geginat J. Identification and characterization of IL-10/IFN-γ-producing effector-like T cells with regulatory function in human blood. J Exp Med 206 (2009) 1009-1017
36. Metzler B., Anderton S.M., Manickasingham S.P., and Wraith D.C. Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide. Immunol Investig 29 (2000) 61-70
37. + memory T lymphocytes. J Immunol 179 (2007) 2389-2396
38. Deibler G.E., Martenson R.E., and Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem 2 (1972) 139-165
39. Bacchetta R., Sartirana C., Levings M.K., Bordignon C., Narula S., and Roncarolo M.G. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 32 (2002) 2237-2245
40. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., and Hafler D.A. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179 (1994) 973-984
41. +ve T-cell subsets to MBP in multiple sclerosis. Clin Exp Immunol 124 (2001) 315-322
42. Sakaguchi S. Regulatory T cells: Key controllers of immunologic self-tolerance. Cell 101 (2000) 455-458
43. Sun E., Zhang L., Zeng Y., Ge Q., Zhao M., and Gao W. Apoptotic cells actively inhibit the expression of CD69 on Con A activated T lymphocytes. Scand J Immunol 51 (2000) 231-236
44. Ariel A., Fredman G., Sun Y.P., Kantarci A., Van Dyke T.E., Luster A.D., et al. Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression. Nat Immunol 7 (2006) 1209-1216
45. Anderton S.M., and Wraith D.C. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 28 (1998) 1251-1261
46. O'Neill E.J., Day M.J., and Wraith D.C. IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE. J Neuroimmunol 178 (2006) 1-8
47. Roncarolo M.G., Bacchetta R., Bordignon C., Narula S., and Levings M.K. Type 1 T regulatory cells. Immunol Rev 182 (2001) 68-79
48. Chang H.D., Helbig C., Tykocinski L., Kreher S., Koeck J., Niesner U., et al. Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3. Eur J Immunol 37 (2007) 807-817
49. Metzler B., Burkhart C., and Wraith D.C. Phenotypic analysis of CTLA-4 and CD28 expression during transient peptide-induced T cell activation in vivo. Int Immunol 11 (1999) 667-675
50. + regulatory cells for their growth, differentiation, and function. J Immunol 176 (2006) 5329-5337